Brief: Tianda Pharmaceuticals' FY profit rises 89.4 pct
30/06/2017 13:06
June 30 (Reuters) - Tianda Pharmaceuticals Ltd 0455.HK
* Profit for year attributable to owners of company
amounted of HK$12.4 million, up 89.4 pct
* Revenue for year amounted to HK$195.5 million, up 1.4 pct
* Board of directors has recommended payment of a final
dividend of HK0.57 cent per share
Source text for Eikon: ID:nHKSc0z81z
Further company coverage: 0455.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Tianda Pharmaceuticals
See all newsBrief: Tianda Pharmaceuticals Says Loss Attributable Expected To Increase To Hk$61 Million For FY
Brief: Tianda Pharmaceuticals Clarifies On Fraudulent Fund Raising Scams
Brief: Tianda Pharmaceuticals Sees Loss Attributable For Interim Period Increase To Not Less Than HK$27 Mln
Brief: Tianda Pharmaceuticals Says Unit Granted Drug Registration Approval Of Ibuprofen Suspension By NMPA
Brief: Tianda Pharmaceuticals Says Drug Registration Approval Of "Nicorandil For Injection" By NMPA